| (Values in U.S. Thousands) | Feb, 2024 | Feb, 2023 | Feb, 2022 | Feb, 2021 | Feb, 2020 |
| Sales | 414,290 | 363,140 | 310,020 | 170,360 | 132,510 |
| Sales Growth | +14.09% | +17.13% | +81.98% | +28.56% | +39.76% |
| Net Income | -99,810 | -459,650 | -123,120 | -50,650 | -51,370 |
| Net Income Growth | +78.29% | -273.33% | -143.08% | +1.40% | +9.08% |
Accolade Inc (ACCD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Accolade Inc. provides personalized, technology-enabled solutions which help people better understand, navigate and utilize the healthcare system. Accolade Inc. is based in SEATTLE.
Fiscal Year End Date: 02/29